Related Experiment Video
Updated: Jun 27, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Fistulogram after arteriovenous dialysis graft thrombectomy should be mandatory
Shakthi D Kumar1, Krishna M Jain, Shikha Jain
1Kalamazoo Center for Medical Studies, Michigan State University, College of Human Medicine, Kalamazoo, Michigan, USA. kumarsh2@msu.edu
Insights
Routine fistulogram after arteriovenous dialysis graft thrombectomy significantly increases lesion identification and improves graft patency. This procedure is recommended to enhance dialysis access longevity and function.
Area of Science:
- Vascular Surgery
- Nephrology
- Interventional Radiology
Background:
- Thrombectomy is a common procedure for prosthetic arteriovenous dialysis grafts.
- Graft patency after thrombectomy can be limited by underlying lesions.
- Identifying and correcting these lesions is crucial for long-term graft function.
Purpose of the Study:
- To evaluate if routine fistulogram after thrombectomy identifies correctable lesions.
- To determine if graft revision improves patency after thrombectomy.
- To assess the impact of routine fistulogram on dialysis graft longevity.
Main Methods:
- Retrospective review of 192 thrombectomy procedures in 61 patients.
- Comparison of outcomes between a group with routine fistulogram (Group I) and a group without (Group II).
- Analysis of lesion identification rates and graft patency based on intervention.
Main Results:
- Routine fistulogram identified significant lesions in 78% of cases, compared to 57% with clinical findings alone (P < 0.05).
- Assisted primary patency was significantly increased when revision was performed (4.84 months) versus no revision (2.9 months) (P < 0.05).
- Routine fistulogram increased the likelihood of encountering significant stenosis.
Conclusions:
- Routine fistulogram post-thrombectomy aids in identifying critical graft lesions.
- Graft revision following fistulogram significantly improves assisted primary patency.
- Routine fistulogram is recommended to enhance arteriovenous dialysis graft longevity.
Abstract:
The purpose of this study was to determine if fistulogram after prosthetic arteriovenous dialysis graft thrombectomy would reveal underlying lesions, which need correction, and if revision would improve graft patency. One hundred and ninety-two open thrombectomy procedures in 61 patients from January 1, 2000 to July 31, 2005 were reviewed retrospectively. All of the study patients were divided into two groups: In Group I fistulogram was carried out and in Group II no fistulogram was performed. Based on the fistulogram or clinical findings, appropriate intervention was carried out. In Group I, of 99 thrombectomy procedures, a significant lesion was identified and revision was carried out in 77 cases (78%). In Group II, of 93 thrombectomy procedures, a significant lesion was identified and revised in 53 cases (57%). A significant abnormality was more likely to be encountered by routine fistulogram than surgical exploration alone, 78 per cent versus 57 per cent (P < 0.05). Assisted primary patency is significantly increased in Group I and II when revision was performed (4.84 months) compared with when no fistulogram and no revision was performed (2.9 months), P < 0.05. Routine fistulogram after thrombectomy of an arteriovenous dialysis graft increases the likelihood of identifying a significant stenosis. Revision of the graft increases the longevity. We recommend routine use of fistulogram during thrombectomy.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Imaging Studies VII: Vascular Imaging
Venous Thrombosis III: Interprofessional Care

